These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 19909255)

  • 1. The DDAH/ADMA pathway in the control of endothelial cell migration and angiogenesis.
    Fiedler LR; Wojciak-Stothard B
    Biochem Soc Trans; 2009 Dec; 37(Pt 6):1243-7. PubMed ID: 19909255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ADMA/DDAH pathway regulates VEGF-mediated angiogenesis.
    Fiedler LR; Bachetti T; Leiper J; Zachary I; Chen L; Renné T; Wojciak-Stothard B
    Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2117-24. PubMed ID: 19778944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene transfer of dimethylarginine dimethylaminohydrolase-2 improves the impairments of DDAH/ADMA/NOS/NO pathway in endothelial cells induced by lysophosphatidylcholine.
    Feng M; Liu L; Guo Z; Xiong Y
    Eur J Pharmacol; 2008 Apr; 584(1):49-56. PubMed ID: 18342305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ADMA/DDAH pathway is a critical regulator of endothelial cell motility.
    Wojciak-Stothard B; Torondel B; Tsang LY; Fleming I; Fisslthaler B; Leiper JM; Vallance P
    J Cell Sci; 2007 Mar; 120(Pt 6):929-42. PubMed ID: 17327280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CT-1 induces angiogenesis by regulating the ADMA/DDAH Pathway.
    Zheng ZZ; Tian Fu X; Liang J; Bing Guo Z
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Dec; 159(4):540-6. PubMed ID: 25732979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The DDAH/ADMA/NOS pathway.
    Tran CT; Leiper JM; Vallance P
    Atheroscler Suppl; 2003 Dec; 4(4):33-40. PubMed ID: 14664901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prominent role of the liver in the elimination of asymmetric dimethylarginine (ADMA) and the consequences of impaired hepatic function.
    Richir MC; Bouwman RH; Teerlink T; Siroen MP; de Vries TP; van Leeuwen PA
    JPEN J Parenter Enteral Nutr; 2008; 32(6):613-21. PubMed ID: 18974239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of dimethylarginine dimethylaminohydrolase reduces tissue asymmetric dimethylarginine levels and enhances angiogenesis.
    Jacobi J; Sydow K; von Degenfeld G; Zhang Y; Dayoub H; Wang B; Patterson AJ; Kimoto M; Blau HM; Cooke JP
    Circulation; 2005 Mar; 111(11):1431-8. PubMed ID: 15781754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of Rac1 activity by ADMA/DDAH regulates pulmonary endothelial barrier function.
    Wojciak-Stothard B; Torondel B; Zhao L; Renné T; Leiper JM
    Mol Biol Cell; 2009 Jan; 20(1):33-42. PubMed ID: 18923147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estradiol counteracts oxidized LDL-induced asymmetric dimethylarginine production by cultured human endothelial cells.
    Monsalve E; Oviedo PJ; García-Pérez MA; Tarín JJ; Cano A; Hermenegildo C
    Cardiovasc Res; 2007 Jan; 73(1):66-72. PubMed ID: 17097077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asymmetric dimethylarginine, an endogenous NOS inhibitor, is actively metabolized in rat erythrocytes.
    Yokoro M; Suzuki M; Murota K; Otsuka C; Yamashita H; Takahashi Y; Tsuji H; Kimoto M
    Biosci Biotechnol Biochem; 2012; 76(7):1334-42. PubMed ID: 22785485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The biology and therapeutic potential of the DDAH/ADMA pathway.
    Arrigoni F; Ahmetaj B; Leiper J
    Curr Pharm Des; 2010; 16(37):4089-102. PubMed ID: 21247398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of dimethylarginine dimethylaminohydrolases in the regulation of endothelial nitric oxide production.
    Pope AJ; Karrupiah K; Kearns PN; Xia Y; Cardounel AJ
    J Biol Chem; 2009 Dec; 284(51):35338-47. PubMed ID: 19820234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacotherapies and their influence on asymmetric dimethylargine (ADMA).
    Maas R
    Vasc Med; 2005 Jul; 10 Suppl 1():S49-57. PubMed ID: 16444869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation by DDAH/ADMA pathway of lipopolysaccharide-induced tissue factor expression in endothelial cells.
    Xin HY; Jiang DJ; Jia SJ; Song K; Wang GP; Li YJ; Chen FP
    Thromb Haemost; 2007 May; 97(5):830-8. PubMed ID: 17479195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for dysregulation of dimethylarginine dimethylaminohydrolase I in chronic hypoxia-induced pulmonary hypertension.
    Millatt LJ; Whitley GS; Li D; Leiper JM; Siragy HM; Carey RM; Johns RA
    Circulation; 2003 Sep; 108(12):1493-8. PubMed ID: 12952847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of puerarin on ADMA-DDAH system in human umbilical vein endothelial cells cultured with oxidized free radical].
    Li JX; Chen J; Deng ZH
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2006 Dec; 26(12):1103-6. PubMed ID: 17205823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of nitric oxide synthase uncoupling in endotoxin-induced acute lung injury: role of asymmetric dimethylarginine.
    Sharma S; Smith A; Kumar S; Aggarwal S; Rehmani I; Snead C; Harmon C; Fineman J; Fulton D; Catravas JD; Black SM
    Vascul Pharmacol; 2010; 52(5-6):182-90. PubMed ID: 19962451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of DDAH/ADMA/NOS pathway in nicotine-induced endothelial dysfunction.
    Jiang DJ; Jia SJ; Yan J; Zhou Z; Yuan Q; Li YJ
    Biochem Biophys Res Commun; 2006 Oct; 349(2):683-93. PubMed ID: 16959216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The DDAH-ADMA-NOS pathway.
    Leiper JM
    Ther Drug Monit; 2005 Dec; 27(6):744-6. PubMed ID: 16404814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.